Treatment of Vancomycin-Resistant Enterococcal Infections in the Immunocompromised Host: Quinupristin-Dalfopristin in Combination with Minocycline

Issam Raad, Ray Hachem, Hend Hanna, Essam Girgawy, Kenneth V. I. Rolston, Estella Whimbey, Rola Husni, Gerald P. Bodey

Antimicrobial Agents and Chemotherapy · 2001 · 43 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

Between February 1994 and November 1998, 56 oncology patients infected with vancomycin-resistant enterococci (VRE) were treated with quinopristin-dalfopristin (Q-D) plus minocycline (MIN). Infections included bacteremia, urinary tract infection, pneumonia, and wound infection. The response rate was 68%, and the most frequent adverse event was arthralgia or myalgia (36%). Q-D-MIN is effective for VRE infection in cancer patients but is associated with a substantial frequency of arthralgia or myalgia.

References

15